DBS Group Research has initiated coverage on Medtecs International with a “buy” recommendation and a target price of $1.30, representing a 43% upside on the stock’s last traded price of 90.5 cents.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply